First-Trimester or Second-Trimester Screening, or Both, for Down's SyndromeFergal D. Malone, Mary E. D’Alton, Jacob A. Canick et al.|New England Journal of Medicine|2005Cited by 1.1k
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)Lorraine Dugoff, Mary E. D’Alton, John C. Hobbins et al.|American Journal of Obstetrics and Gynecology|2004Cited by 620
Delayed Childbearing and the Outcome of PregnancyGertrud S. Berkowitz, Richard L. Berkowitz, Mary Louise Skovron et al.|New England Journal of Medicine|1990Cited by 429
Pregnancy Loss Rates After Midtrimester AmniocentesisKeith Eddleman, Mary E. D’Alton, Fergal D. Malone et al.|Obstetrics and Gynecology|2006Cited by 322
Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening studyJoshua L. Weiss, Mary E. D’Alton, Fergal D. Malone et al.|American Journal of Obstetrics and Gynecology|2004Cited by 273